Plain-English translation of NCT05654454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a new medication called (made by Mabscale LLC) works just as well and as safely as Avastin®, an already-approved drug for advanced lung cancer. Both medications will be given alongside two chemotherapy drugs called and . The goal is to see if this new version is equivalent to the existing treatment so it can potentially become available to patients.
Avastin® is an effective treatment for advanced lung cancer, but it is expensive and not available everywhere. This trial exists to see if a new version of this medication works just as well, which could make treatment more accessible and affordable for patients who need it.
You likely qualify if…
You likely don't qualify if…
You would receive intravenous (IV) infusions of the medication plus two chemotherapy drugs on the first day of each 3-week cycle, for up to 6 cycles (about 4.5 months). If your cancer responds well, you would then continue receiving the medication alone every 3 weeks as long as it is helping. You will have regular blood tests and scans to check how well the treatment is working and to watch for any side effects.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Russia